In the race for the coronavirus vaccine, Russia claims to have a head start. The Russian Ministry of Health has granted regulatory approval for the first anti-Covid-19 vaccine developed by the Nikolai-Gamaleia Institute, a state research center in epidemiology and microbiology located in Moscow, the Russian president announced on Tuesday. Vladimir Poutine.
Read also: Coronavirus: Putin claims an effective vaccine even before the start of phase 3 of the trials
While the World Health Organization (WHO) calls for caution by recalling that the "prequalification" and approval of a vaccine go through "rigorous" procedures , in Russia, we are trying to calm concerns. "There is no reason to put obstacles in the way of vaccine registration , " Nikolai Briko, head of the epidemiology department at the Ivan-Setchenov Medical University in Moscow, told the agency on Tuesday. Russian RIA Novosti. "The vaccine did not come out of nowhere" , he explains because the technology used for this new vaccine has already been tested by the Nikolaï-Gamaleïa Institute.
This article is for subscribers only. You have 67% left to discover.
Subscribe: 1 € for 2 months
Cancellable at any time
Enter your emailAlready subscribed? Log in